Multiple spider telangiectasias in a breast cancer patient on T-DM1 treatment

被引：4
|
作者：
Ruiz-Rivero, Juncal [1 ,2 ]
Horcajada-Reales, Celia [1 ,2 ]
Tardio, Juan C. [1 ,3 ]
Manuel Borbujo-Martinez, Jesus [1 ,2 ]
机构：
[1] Hosp Univ Sagrat Cor, Barcelona, Spain
[2] Hosp Univ Fuenlabrada, Dept Clin & Surg Dermatol & Venereol, Madrid, Spain
[3] Hosp Univ Fuenlabrada, Dept Pathol Anat, Madrid, Spain
来源：
ANAIS BRASILEIROS DE DERMATOLOGIA | 2018年 / 93卷 / 06期
关键词：
TRASTUZUMAB EMTANSINE;
D O I：
10.1590/abd1806-4841.20187968
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：938 / 939
页数：2
相关论文
共 50 条
  • [31] Activity of T-DM1 in HER2-positive breast cancer brain metastases
    Bartsch, R.
    Berghoff, A. S.
    Rudas, M.
    Bergen, E.
    Gnant, M.
    Dieckmann, K.
    Pinker, K.
    Zielinski, C. C.
    Preusser, M.
    Steger, G. G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S184 - S184
  • [32] PATIENT-REPORTED OUTCOMES (PROS) IN HER2+METASTATIC BREAST CANCER (MBC) TREATED WITH T-DM1
    Agresta, S.
    Hurvitz, S.
    Lalla, D.
    Mathias, S.
    Burington, B.
    Sloan, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 345 - 345
  • [33] Imaging HER2 in response to T-DM1 therapy in Breast Cancer Xenografts
    Massicano, Adriana
    Aweda, Tolulope
    Marquez-Nostra, Bernadette
    El Sayed, Retta
    Beacham, Rebecca
    Lapi, Suzanne
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [34] Activity of T-DM1 in Her2-positive breast cancer brain metastases
    Rupert Bartsch
    Anna S. Berghoff
    Ursula Vogl
    Margaretha Rudas
    Elisabeth Bergen
    Peter Dubsky
    Karin Dieckmann
    Katja Pinker
    Zsuzsanna Bago-Horvath
    Arik Galid
    Leopold Oehler
    Christoph C. Zielinski
    Michael Gnant
    Guenther G. Steger
    Matthias Preusser
    Clinical & Experimental Metastasis, 2015, 32 : 729 - 737
  • [35] T-DM1 in HER2-positive breast cancer brain metastases (BM).
    Bartsch, Rupert
    Berghoff, Anna Sophie
    Rudas, Margareta
    Bergen, Elisabeth
    Gnant, Michael
    Dieckmann, Karin
    Pinker, Katja
    Zielinski, Christoph
    Steger, Guenther G.
    Preusser, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Activity of T-DM1 in Her2-positive breast cancer brain metastases
    Bartsch, Rupert
    Berghoff, Anna S.
    Vogl, Ursula
    Rudas, Margaretha
    Bergen, Elisabeth
    Dubsky, Peter
    Dieckmann, Karin
    Pinker, Katja
    Bago-Horvath, Zsuzsanna
    Galid, Arik
    Oehler, Leopold
    Zielinski, Christoph C.
    Gnant, Michael
    Steger, Guenther G.
    Preusser, Matthias
    CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (07) : 729 - 737
  • [37] T-DM1 is active in Her2-positive breast cancer brain metastases
    Bartsch, R.
    Berghoff, A.
    Rudas, M.
    Bergen, E.
    Gnant, M.
    Dieckmann, K.
    Pinker, K.
    Zielinski, C. C.
    Steger, G. G.
    Preusser, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 195 - 195
  • [38] T-DM1 impresses at ASCO
    Malini Guha
    Nature Biotechnology, 2012, 30 (8) : 728 - 728
  • [39] Predicting T-DM1 response
    Collingridge, David
    LANCET ONCOLOGY, 2019, 20 (08): : 1057 - 1057
  • [40] Trastuzumab emtansine (T-DM1) as adjuvant treatment of HER2-positive early breast cancer: safety and efficacy
    Molinelli, Chiara
    Parisi, Francesca
    Razeti, Maria Grazia
    Arecco, Luca
    Cosso, Maurizio
    Fregatti, Piero
    Del Mastro, Lucia
    Poggio, Francesca
    Lambertini, Matteo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (03) : 241 - 250
12345